Entrepreneurs and Industry Execs to Present at 2012 Leaders Forum
Founders and CEOs of several startup and emerging neurotechnology firms are scheduled to give presentations at the 2012 Neurotech Leaders Forum, which will take place October 22-23 at the Radisson Hotel San Francisco Airport in Brisbane, CA. Among the entrepreneurs making presentations at the event are Jon Snyder, CEO of Neuros Medical in Cleveland, OH, Lee Gerdes, founder and CEO of Brain State Technologies, Inc. in Scottsdale, AZ, Laura Tyler Perryman, executive director of Stimwave Technologies in Scottsdale, AZ, and Scott Meier, CEO of Cervel Neurotech in San Mateo, CA.
Jaimie Henderson, director of stereotactic and functional neurosurgery at Stanford University School of Medicine, will deliver the keynote address on Monday, October 22 on the subject of transitioning neuromodulation technology from lab to clinic. Henderson is a pioneer in deep brain stimulation and an expert in the surgical treatment of movement disorders and chronic pain. He is active in research to improve stereotactic navigation and the efficacy of neuromodulatory therapies for movement disorders, pain, and other neurological diseases. Henderson received his B.A. degree from Washington University in St. Louis and his M.D. from Rush Medical College.
Other speakers at this year's event include Robert Greenberg, CEO of Second Sight Medical Products, Ben Pless, CEO of Autonomic Technologies, Inc., George Carpenter, CEO of CNS Response, Geoff Thrope, CEO of NDI Medical, and Pete Lando, vice-president of business development at St. Jude Medical. Neurotech Business Report editor James Cavuoto will offer on overview of the state of the neurotechnology industry on the first day of the event. Other sessions will be devoted to progress in neural interfaces, the path to commercialization, and the investment outlook for neurotechnology. Venture capital professionals participating in this year's event include Manuel Lopez Figueroa from Bay City Capital, Paul Grand from RCT BioVentures, Roger Quy from Technology Partners, and Kevin Wasserstein from Versant Ventures.
The second day of the conference will be devoted to noninvasive neurotechnology systems, including neurosensing devices, surface stimulation devices, and consumer-oriented neurotechnolgy systems. A session on advances in neuromarker technology will feature Chad Bouton, a neurotech researcher at Battelle Memorial Institute in Columbus, OH.
For more information on this year's event, contact Neurotech Reports at 415 546 1259.